Want to join the conversation?
In Oct. 2015, $BMY and $FPRX entered into an exclusive worldwide licensing and collaboration agreement for the development and commercialization of $FPRX's colony stimulating factor 1 receptor (CSF1R) antibody program. In consideration for licensing rights, $BMY will make an upfront payment of $350MM, which will be included in R&D expense.
$KMB down close to 4% after it misses on earnings and revenue. Forecasts are lower for the year.
It is official, with $T buying $TWX, it looks like distributors want to own the content production too. Expect some good competition between Netflix ($NFLX), AT&T, Comcast ($CMCSA) and others. However, will this be good for the consumers will not be decided soon.
$NFLX a monster move, going up. Expect making some money on Monday.